Latest News

Fintech Innovation a Solid Alternative to Established Options

FinTech money transfer companies have dramatically changed the way we move money from one country to another. The traditional model which espouses banks as the de facto money transmission mechanism is quickly losing favour with clients around the world. For starters, banks and institutional financial organizations eat into more of every $1 sent abroad than […]

Solar Capital Ltd. (NASDAQ:SLRC) Expected to Announce Earnings of $0.44 Per Share

Equities analysts predict that Solar Capital Ltd. (NASDAQ:SLRC) will post earnings of $0.44 per share for the current fiscal quarter, Zacks Investment Research reports. Three analysts have issued estimates for Solar Capital’s earnings. The highest EPS estimate is $0.45 and the lowest is $0.43. Solar Capital posted earnings per share of $0.45 in the same […]

Sirius XM Holdings Inc (NASDAQ:SIRI) Expected to Post Earnings of $0.05 Per Share

Wall Street brokerages expect Sirius XM Holdings Inc (NASDAQ:SIRI) to announce earnings per share (EPS) of $0.05 for the current quarter, Zacks reports. Five analysts have provided estimates for Sirius XM’s earnings, with the lowest EPS estimate coming in at $0.05 and the highest estimate coming in at $0.06. Sirius XM posted earnings of $0.06 […]

Acme United (NYSEAMERICAN:ACU) Issues FY 2019 Earnings Guidance

Acme United (NYSEAMERICAN:ACU) issued an update on its FY 2019 earnings guidance on Friday morning. The company provided EPS guidance of $1.41-1.50 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.47. The company issued revenue guidance of $140-143 million, compared to the consensus revenue estimate of $141.46 million. Shares of NYSEAMERICAN:ACU […]

Genuine Parts (NYSE:GPC) Issues FY19 Earnings Guidance

Genuine Parts (NYSE:GPC) updated its FY19 earnings guidance on Thursday. The company provided EPS guidance of $5.65-5.75 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.91. The company issued revenue guidance of $19.58-19.77 billion (+4.5-5.5%), compared to the consensus revenue estimate of $19.55 billion.Genuine Parts also updated its FY 2019 guidance […]

Dover (NYSE:DOV) Issues FY19 Earnings Guidance

Dover (NYSE:DOV) updated its FY19 earnings guidance on Thursday. The company provided EPS guidance of $5.75-5.85 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.81. Dover also updated its FY 2019 guidance to $5.75-5.85 EPS. DOV has been the subject of several recent analyst reports. Zacks Investment Research downgraded shares of […]

Taiwan Semiconductor Mfg. (NYSE:TSM) Releases Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Taiwan Semiconductor Mfg. (NYSE:TSM) posted its earnings results on Thursday. The semiconductor company reported $0.41 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.42 by ($0.01), Morningstar.com reports. Taiwan Semiconductor Mfg. had a return on equity of 19.01% and a net margin of 31.42%. The firm had revenue of $241 billion […]

Philip Morris International (NYSE:PM) Releases FY 2019 Earnings Guidance

Philip Morris International (NYSE:PM) updated its FY 2019 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $5.14-5.14 for the period, compared to the Thomson Reuters consensus estimate of $5.16. Philip Morris International also updated its FY19 guidance to $5.14 EPS. Several research firms recently weighed in on PM. Morgan Stanley […]

Regenxbio (NASDAQ:RGNX) Cut to “Sell” at Zacks Investment Research

Zacks Investment Research lowered shares of Regenxbio (NASDAQ:RGNX) from a hold rating to a sell rating in a report issued on Wednesday morning, Zacks.com reports. According to Zacks, “REGENXBIO Inc. is a biotechnology company. The Company focuses on the development, commercialization and licensing of recombinant adeno-associated virus gene therapy. Its products candidates include RGX-501, for […]

Nabriva Therapeutics (NASDAQ:NBRV) Downgraded by Zacks Investment Research

Zacks Investment Research downgraded shares of Nabriva Therapeutics (NASDAQ:NBRV) from a buy rating to a hold rating in a research report released on Wednesday morning, Zacks.com reports. According to Zacks, “Nabriva Therapeutics is a biopharmaceutical company engaged in the research and development of new medicines to treat serious bacterial infections, with a focus on the […]

Pennantpark Floating Rate Capital (NASDAQ:PFLT) Stock Rating Lowered by Zacks Investment Research

Zacks Investment Research lowered shares of Pennantpark Floating Rate Capital (NASDAQ:PFLT) from a buy rating to a hold rating in a report published on Wednesday, Zacks.com reports. According to Zacks, “PennantPark Floating Rate Capital Ltd. is a business development company. It is a closed-end, externally managed and non-diversified investment company. Its investment objectives are to […]

Redfin (NASDAQ:RDFN) Lifted to Positive at Susquehanna Bancshares

Susquehanna Bancshares upgraded shares of Redfin (NASDAQ:RDFN) from a neutral rating to a positive rating in a research note issued to investors on Wednesday, BenzingaRatingsTable reports. The firm currently has $23.00 price target on the stock. Several other brokerages have also recently weighed in on RDFN. BidaskClub raised Acceleron Pharma from a strong sell rating […]

VOLVO AB/ADR (OTCMKTS:VLVLY) Announces Earnings Results, Beats Estimates By $0.08 EPS

VOLVO AB/ADR (OTCMKTS:VLVLY) announced its quarterly earnings results on Thursday. The company reported $0.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.50 by $0.08, Morningstar.com reports. VOLVO AB/ADR had a return on equity of 24.85% and a net margin of 7.43%. The company had revenue of $12.78 billion for the […]

Novartis (NYSE:NVS) Announces Earnings Results, Beats Expectations By $0.14 EPS

Novartis (NYSE:NVS) issued its quarterly earnings results on Thursday. The company reported $1.34 EPS for the quarter, topping the Zacks’ consensus estimate of $1.20 by $0.14, Briefing.com reports. The business had revenue of $11.76 billion for the quarter, compared to analyst estimates of $11.45 billion. Novartis had a return on equity of 17.43% and a […]

Bank of New York Mellon (NYSE:BK) Posts Earnings Results, Beats Expectations By $0.07 EPS

Bank of New York Mellon (NYSE:BK) announced its quarterly earnings data on Wednesday. The bank reported $1.01 earnings per share for the quarter, beating analysts’ consensus estimates of $0.94 by $0.07, RTT News reports. The firm had revenue of $3.92 billion for the quarter, compared to analyst estimates of $3.92 billion. Bank of New York […]

Honeywell International (NYSE:HON) Releases FY 2019 Earnings Guidance

Honeywell International (NYSE:HON) issued an update on its FY 2019 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $7.95-8.15 for the period, compared to the Thomson Reuters consensus estimate of $8.10. The company issued revenue guidance of $36.7-37.2 billion, compared to the consensus revenue estimate of $37.17 billion.Honeywell International […]

Royal Bank of Canada Raises Cintas (NASDAQ:CTAS) Price Target to $267.00

Cintas (NASDAQ:CTAS) had its price objective raised by Royal Bank of Canada to $267.00 in a research note published on Wednesday, The Fly reports. Royal Bank of Canada currently has an outperform rating on the business services provider’s stock. Several other analysts have also commented on the stock. Credit Suisse Group set a GBX 3,090 […]

IPG Photonics (NASDAQ:IPGP) Earns Buy Rating from Needham & Company LLC

Needham & Company LLC reissued their buy rating on shares of IPG Photonics (NASDAQ:IPGP) in a research note released on Wednesday, The Fly reports. Needham & Company LLC currently has a $150.00 price target on the semiconductor company’s stock. Other analysts have also issued research reports about the stock. Zacks Investment Research lowered shares of […]

Kala Pharmaceuticals (NASDAQ:KALA) Downgraded by Zacks Investment Research

Zacks Investment Research lowered shares of Kala Pharmaceuticals (NASDAQ:KALA) from a buy rating to a hold rating in a research note issued to investors on Wednesday morning, Zacks.com reports. According to Zacks, “Kala Pharmaceuticals, Inc. is a biopharmaceutical company. It focused on the development and commercialization of therapeutics through its nanoparticle-based Mucus Penetrating Particles technology. […]

IAC/InterActiveCorp (NASDAQ:IAC) Lowered to Hold at Zacks Investment Research

Zacks Investment Research cut shares of IAC/InterActiveCorp (NASDAQ:IAC) from a strong-buy rating to a hold rating in a report released on Wednesday morning, Zacks.com reports. According to Zacks, “IAC is a leading media and Internet company. It is organized into four segments: The Match Group, which consists of dating, education and fitness businesses with brands […]

Loop Industries (NASDAQ:LOOP) Upgraded by Zacks Investment Research to Buy

Zacks Investment Research upgraded shares of Loop Industries (NASDAQ:LOOP) from a hold rating to a buy rating in a report released on Wednesday morning, Zacks.com reports. The brokerage currently has $14.00 price objective on the financial services provider’s stock. According to Zacks, “Loop Industries Inc. is a technology company. It created a revolutionary process which […]

Insmed (NASDAQ:INSM) Downgraded by BidaskClub

BidaskClub lowered shares of Insmed (NASDAQ:INSM) from a sell rating to a strong sell rating in a research report sent to investors on Wednesday morning, BidAskClub reports. A number of other analysts also recently issued reports on the company. ValuEngine downgraded Zynerba Pharmaceuticals from a buy rating to a hold rating in a research report […]

BidaskClub Upgrades LKQ (NASDAQ:LKQ) to Hold

BidaskClub upgraded shares of LKQ (NASDAQ:LKQ) from a sell rating to a hold rating in a research note published on Wednesday morning, BidAskClub reports. Other equities research analysts have also recently issued research reports about the stock. Raymond James set a $33.00 price target on shares of LKQ and gave the company a buy rating […]

Gossamer Bio (NASDAQ:GOSS) Downgraded by Zacks Investment Research

Zacks Investment Research downgraded shares of Gossamer Bio (NASDAQ:GOSS) from a buy rating to a hold rating in a report released on Wednesday, Zacks.com reports. According to Zacks, “Gossamer Bio Inc. is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing and commercializing therapeutics in the areas of immunology, inflammation and oncology. The company’s […]

Northern Trust (NASDAQ:NTRS) Downgraded by BidaskClub

BidaskClub cut shares of Northern Trust (NASDAQ:NTRS) from a hold rating to a sell rating in a research note published on Wednesday morning, BidAskClub reports. A number of other brokerages have also issued reports on NTRS. Wells Fargo & Co reaffirmed a hold rating and set a $11.00 target price on shares of Coty in […]

Heartland Express (NASDAQ:HTLD) Announces Quarterly Earnings Results, Beats Expectations By $0.03 EPS

Heartland Express (NASDAQ:HTLD) posted its quarterly earnings data on Thursday. The transportation company reported $0.27 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.24 by $0.03, Briefing.com reports. Heartland Express had a return on equity of 13.22% and a net margin of 14.00%. The company had revenue of $142.14 […]

CSX (NASDAQ:CSX) Earns “Market Perform” Rating from Cowen

Cowen reiterated their market perform rating on shares of CSX (NASDAQ:CSX) in a report published on Wednesday morning, Briefing.com Automated Import reports. They currently have a $78.00 price objective on the transportation company’s stock, down from their prior price objective of $80.00. CSX has been the topic of a number of other reports. Credit Suisse […]

Cathay General Bancorp (NASDAQ:CATY) Posts Earnings Results, Beats Expectations By $0.04 EPS

Cathay General Bancorp (NASDAQ:CATY) released its earnings results on Wednesday. The bank reported $0.90 EPS for the quarter, topping analysts’ consensus estimates of $0.86 by $0.04, Briefing.com reports. Cathay General Bancorp had a net margin of 34.86% and a return on equity of 12.73%. The business had revenue of $156.17 million for the quarter, compared […]

Danaher (NYSE:DHR) Updates FY 2019 Earnings Guidance

Danaher (NYSE:DHR) issued an update on its FY 2019 earnings guidance on Thursday morning. The company provided earnings per share guidance of $4.75-4.80 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.78. Danaher also updated its FY19 guidance to $4.75-4.80 EPS. Several equities research analysts recently issued reports on […]

Coca-Cola Consolidated (NASDAQ:COKE) Downgraded to Sell at BidaskClub

BidaskClub cut shares of Coca-Cola Consolidated (NASDAQ:COKE) from a hold rating to a sell rating in a research report released on Wednesday morning, BidAskClub reports. NASDAQ:COKE opened at $291.27 on Wednesday. The firm has a market capitalization of $2.73 billion, a price-to-earnings ratio of 47.71 and a beta of 0.80. Coca-Cola Consolidated has a 1-year […]

Osisko gold royalties (NYSE:OR) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of Osisko gold royalties (NYSE:OR) from a sell rating to a hold rating in a report issued on Wednesday, Zacks.com reports. According to Zacks, “Osisko Gold Ltd is a mining company which is engaged in exploration and mining for gold and other precious metals. Osisko Gold Ltd is headquartered in […]

DA Davidson Boosts Commerce Bancshares (NASDAQ:CBSH) Price Target to $62.00

Commerce Bancshares (NASDAQ:CBSH) had its target price hoisted by DA Davidson to $62.00 in a research note released on Wednesday morning, The Fly reports. The brokerage currently has a neutral rating on the financial services provider’s stock. Several other research analysts have also recently weighed in on the stock. Zacks Investment Research raised shares of […]

Park Hotels & Resorts (NYSE:PK) Cut to Sell at Zacks Investment Research

Zacks Investment Research lowered shares of Park Hotels & Resorts (NYSE:PK) from a hold rating to a sell rating in a research report released on Wednesday, Zacks.com reports. According to Zacks, “Park Hotels & Resorts Inc. is a lodging Real Estate Company. The company operates luxury hotels and resorts in USA and international market. Park […]

Farmers National Banc (NASDAQ:FMNB) Downgraded by ValuEngine

ValuEngine downgraded shares of Farmers National Banc (NASDAQ:FMNB) from a hold rating to a sell rating in a research note issued to investors on Wednesday, ValuEngine reports. A number of other brokerages also recently weighed in on FMNB. Raymond James started coverage on shares of PennantPark Investment in a report on Monday, April 29th. They […]

Eiger Biopharmaceuticals (NASDAQ:EIGR) Raised to Buy at Zacks Investment Research

Zacks Investment Research upgraded shares of Eiger Biopharmaceuticals (NASDAQ:EIGR) from a hold rating to a buy rating in a research note published on Tuesday morning, Zacks.com reports. The brokerage currently has $12.00 target price on the biotechnology company’s stock. According to Zacks, “Eiger BioPharmaceuticals, Inc. is a biopharmaceutical company which develops and manufactures drugs and […]

Gladstone Investment (NASDAQ:GAIN) Rating Lowered to Hold at Zacks Investment Research

Zacks Investment Research cut shares of Gladstone Investment (NASDAQ:GAIN) from a buy rating to a hold rating in a research report released on Tuesday morning, Zacks.com reports. According to Zacks, “Gladstone Investment Corporation is an investment company that seeks to make equity-type investments in small and mid-sized private businesses in the U.S. “ A number […]

Zacks Investment Research Lowers DiaMedica Therapeutics (NASDAQ:DMAC) to Hold

Zacks Investment Research cut shares of DiaMedica Therapeutics (NASDAQ:DMAC) from a buy rating to a hold rating in a research report released on Tuesday morning, Zacks.com reports. According to Zacks, “DiaMedica Therapeutics Inc. is a biopharmaceutical company. It engages in the development of novel recombinant proteins and monoclonal antibodies. The companys lead product principally consists […]

Snap-on (NYSE:SNA) Releases Earnings Results, Beats Estimates By $0.01 EPS

Snap-on (NYSE:SNA) announced its earnings results on Thursday. The company reported $3.22 EPS for the quarter, topping the Zacks’ consensus estimate of $3.21 by $0.01, RTT News reports. The firm had revenue of $951.30 million during the quarter, compared to analysts’ expectations of $959.33 million. Snap-on had a return on equity of 21.40% and a […]

eBay (NASDAQ:EBAY) Releases FY19 Earnings Guidance

eBay (NASDAQ:EBAY) updated its FY19 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $2.70-2.75 for the period, compared to the Thomson Reuters consensus estimate of $2.70. The company issued revenue guidance of $10.75-10.83 billion, compared to the consensus revenue estimate of $10.92 billion.eBay also updated its FY 2019 guidance to […]

GATX (NYSE:GATX) Issues Earnings Results

GATX (NYSE:GATX) announced its quarterly earnings data on Thursday. The transportation company reported $1.78 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.32 by $0.46, Briefing.com reports. GATX had a return on equity of 10.21% and a net margin of 14.88%. The company had revenue of $359.40 million for the quarter, […]

BRAINSWAY LTD/S (NASDAQ:BWAY) Stock Rating Lowered by Zacks Investment Research

Zacks Investment Research downgraded shares of BRAINSWAY LTD/S (NASDAQ:BWAY) from a buy rating to a hold rating in a research note issued to investors on Tuesday morning, Zacks.com reports. According to Zacks, “BrainsWay Ltd. is a commercial stage medical device company. It is focused on the development and sale of non-invasive neuromodulation products using the […]